AU612267B2 - Medicaments - Google Patents

Medicaments

Info

Publication number
AU612267B2
AU612267B2 AU36584/89A AU3658489A AU612267B2 AU 612267 B2 AU612267 B2 AU 612267B2 AU 36584/89 A AU36584/89 A AU 36584/89A AU 3658489 A AU3658489 A AU 3658489A AU 612267 B2 AU612267 B2 AU 612267B2
Authority
AU
Australia
Prior art keywords
medicaments
treatment
human beings
bolus injections
thrombotic disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU36584/89A
Other languages
English (en)
Other versions
AU3658489A (en
Inventor
Adam Frederik Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10638996&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU612267(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU3658489A publication Critical patent/AU3658489A/en
Application granted granted Critical
Publication of AU612267B2 publication Critical patent/AU612267B2/en
Assigned to BOEHRINGER INGELHEIM INTERNATIONAL GMBH reassignment BOEHRINGER INGELHEIM INTERNATIONAL GMBH Alteration of Name(s) in Register under S187 Assignors: WELLCOME FOUNDATION LIMITED, THE
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AU36584/89A 1988-06-20 1989-06-19 Medicaments Expired AU612267B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8814604 1988-06-20
GB888814604A GB8814604D0 (en) 1988-06-20 1988-06-20 Medicaments

Publications (2)

Publication Number Publication Date
AU3658489A AU3658489A (en) 1990-01-11
AU612267B2 true AU612267B2 (en) 1991-07-04

Family

ID=10638996

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36584/89A Expired AU612267B2 (en) 1988-06-20 1989-06-19 Medicaments

Country Status (14)

Country Link
EP (1) EP0352897B1 (cg-RX-API-DMAC7.html)
JP (1) JPH0618782B2 (cg-RX-API-DMAC7.html)
AT (1) ATE74275T1 (cg-RX-API-DMAC7.html)
AU (1) AU612267B2 (cg-RX-API-DMAC7.html)
CA (1) CA1338551C (cg-RX-API-DMAC7.html)
DE (1) DE68901114D1 (cg-RX-API-DMAC7.html)
DK (1) DK175179B1 (cg-RX-API-DMAC7.html)
ES (1) ES2033096T3 (cg-RX-API-DMAC7.html)
GB (1) GB8814604D0 (cg-RX-API-DMAC7.html)
GR (1) GR3004181T3 (cg-RX-API-DMAC7.html)
HK (1) HK46597A (cg-RX-API-DMAC7.html)
IE (1) IE61399B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ229611A (cg-RX-API-DMAC7.html)
ZA (1) ZA894647B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0709096A2 (de) * 1991-04-16 1996-05-01 Roche Diagnostics GmbH Pharmazeutische Verpackungseinheit enthaltend Plasminogenaktivatoren zur Mehrfachbolusgabe
DK125693D0 (cg-RX-API-DMAC7.html) * 1993-11-05 1993-11-05 Novo Nordisk As

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8513358D0 (en) * 1985-05-28 1985-07-03 Wellcome Found Formulation
DE3617753A1 (de) * 1985-05-28 1986-12-04 The Wellcome Foundation Ltd., London Gewebe-plasminogenaktivator, diesen enthaltende pharmazeutische formulierungen sowie ihre herstellung und ihre verwendung in der human- und veterinaermedizin
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
EP0218112B1 (en) * 1985-09-10 1992-12-09 Eisai Co., Ltd. Composition containing tissue plasminogen activator
EP0252004A1 (de) * 1986-06-26 1988-01-07 Ciba-Geigy Ag Pharmazeutische Zusammensetzungen für die parenterale Applikation

Also Published As

Publication number Publication date
DK175179B1 (da) 2004-06-28
HK46597A (en) 1997-04-18
ZA894647B (en) 1991-02-27
ES2033096T3 (es) 1993-03-01
EP0352897B1 (en) 1992-04-01
GR3004181T3 (cg-RX-API-DMAC7.html) 1993-03-31
ATE74275T1 (de) 1992-04-15
IE891977L (en) 1989-12-20
CA1338551C (en) 1996-08-27
IE61399B1 (en) 1994-11-02
DE68901114D1 (de) 1992-05-07
GB8814604D0 (en) 1988-07-27
EP0352897A1 (en) 1990-01-31
JPH0618782B2 (ja) 1994-03-16
JPH0272124A (ja) 1990-03-12
AU3658489A (en) 1990-01-11
DK301589D0 (da) 1989-06-19
DK301589A (da) 1989-12-21
NZ229611A (en) 1991-12-23

Similar Documents

Publication Publication Date Title
US5263967B1 (en) Medical instrument with dual action drive
AU4748990A (en) Hypodermic syringe
HUT59017A (en) Injection syringe
DE3878889D1 (de) Packung und verpackung mit sauerstoff absorbierenden mitteln.
EP0318201A3 (en) Inhibition of arterial thrombotic occlusion or thromboembolism
GB2237745A (en) Hypodermic syringe
AU3008092A (en) Novel use of modafinil
AU4135289A (en) Pharmaceutically active combination
GB8802349D0 (en) Ampoule with luer
AU3713393A (en) Intravenous catheter with needle guard
AU3832289A (en) Single-injection syringe
ATE104151T1 (de) Trombosebehandlung mit fibrinolytika und prostacyclinen.
AU625718B2 (en) Tracheobronchodilator
EP0295280A4 (en) Use of protoporphyrin and stannic mesoporphyrin for the manufacture of a medicament for the treatment of psoriasis.
DE58900609D1 (de) Raupenfahrzeug mit haupt- und zusatztreibraedern.
EP0200156A3 (en) Use of an aqueous solution of a chlorite matrix for treating tumours
NZ230327A (en) Synergistic combination of t-pa and activated protein c (apc)
AU612267B2 (en) Medicaments
AU5600386A (en) Controlling cure rate in polyurethanes
ZA857721B (en) Process for treatment of rheumatic diseases
FR2578255B1 (fr) Acides 8-oxo-2-oxa-1-azabicyclo(4.2.0)octane-3-carboxyliques a action therapeutique
AU7719491A (en) Therapeutic compound
GR3005387T3 (cg-RX-API-DMAC7.html)
AU104178S (en) A sulky wheel
IE883395L (en) Medicament with antiemetic action